Contact us today to learn more about available treatment options and how we can support your vision care needs. Our team is here to answer your questions, provide helpful information, and help you understand the options available to you. Take the next step toward caring for your vision and maintaining the quality of life you value.

ValedaTM PBM uses a light-based therapy called photobiomodulation (PBM) to help stimulate energy production in the cells of your eyes.2

• Treatments are given at your doctor's office or clinic and may take 10 minutes or less to complete.

• ValedaTM PBM is noninvasive, which means there are no needles; only light is used

• Your pupils are not dilated, and there is no anesthesia. This means you are free to carry on with your daily activities after treatment.
  

Important Product Information

Indications for Use:

The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best-corrected visual acuity of 20/32 through 20/70 and who have dry age-related macular degeneration

(AMD) characterized by:

• The presence of at least 3 medium drusen (> 63 μm and = 125 μm in diameter), or large drusen (> 125 μm in diameter), or non-central geographic atrophy, AND

• The absence of neovascular maculopathy or central-involving

geographic atrophy. After about two years, the Valeda Light Delivery System treatment provides improved mean visual acuity of approximately one line of visual acuity (ETDRS) compared to those not receiving the treatment.

Contraindications for Use:

As a precaution, patients have not been tested and should not be treated with Valeda if they have any known photosensitivity to yellow light, red light, or near-infrared radiation (NIR), or if they have a history of light-activated central nervous system disorders (e.g., epilepsy, migraine). In addition, patients should not receive treatment within 30 days of using photosensitizing agents (e.g., topicals, injectables) that are affected by 590, 660, and/or 850 nm light before consulting with their physician.

Precautions:

It is possible that treatment benefit may not persist significantly after treatment is stopped. The clinical study provided no significant data concerning the safety and effectiveness of the device should treatments be applied more frequently than described in this manual, or if more than 54 total treatments are delivered per eye.